Boone Capital Management’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.6M | Buy |
641,448
+38,130
| +6% | +$1.94M | 14% | 2 |
|
|
2025
Q1 | $27.2M | Buy |
603,318
+21,475
| +4% | +$967K | 9.25% | 3 |
|
|
2024
Q4 | $24.1M | Buy |
581,843
+38,000
| +7% | +$1.57M | 8.12% | 4 |
|
|
2024
Q3 | $21.2M | Buy |
543,843
+20,164
| +4% | +$786K | 5.5% | 7 |
|
|
2024
Q2 | $17.9M | Buy |
523,679
+71,781
| +16% | +$2.45M | 4.67% | 9 |
|
|
2024
Q1 | $11.4M | Sell |
451,898
-38,241
| -8% | -$961K | 2.3% | 19 |
|
|
2023
Q4 | $14.5M | Buy |
490,139
+100,348
| +26% | +$2.96M | 3.38% | 16 |
|
|
2023
Q3 | $12.3M | Buy |
+389,791
| New | +$12.3M | 3.89% | 12 |
|